Sofocure- v Tablet
By Sofocure-V
Rx
28 Tablet in a Strip

Composition
Sofosbuvir(400mg) + Velpatasvir(100mg)

Manufacturer - Emcure Pharmaceuticals Ltd
255/2, Hinjawadi, Pune - 411057, India

Expires on or after
October, 2026

liver
Sofocure- v Tablet is considered safe for patients with liver disease. It is not necessary to adjust the dosage of this medicine specifically due to liver issues. It is important to note that if you have any kidney disease, it is advisable to inform your doctor. Some patients may require regular monitoring of liver function tests while using Sofocure- v Tablet.

kidney
Sofocure- v Tablet requires caution for individuals with severe kidney disease. Dosage adjustment may be necessary, so consulting a doctor is important. Limited data exists on its use in such cases. No dose adjustment is advised for mild to moderate kidney issues.

alcohol
Consult your doctor when cosuming alcohol with Sofocure- v Tablet.

driving
When using Sofocure- v Tablet, be cautious while driving as it may cause dizziness and blurred vision, affecting your ability to drive. This risk increases when taken with other medications for hepatitis C infection.

pregnancy
Sofocure- v Tablet is generally considered safe during pregnancy, with low risks based on animal studies. Limited human studies are available.

breastfeeding
Sofocure- v Tablet is considered safe during breastfeeding based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹21227
₹23227
8.61% OFF
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024